Blocking IL-1beta to slow down progression of ALS?
- PMID: 20624959
- PMCID: PMC2919971
- DOI: 10.1073/pnas.1007946107
Blocking IL-1beta to slow down progression of ALS?
Conflict of interest statement
Conflict of interest statement: Both authors received consulting fees from Novartis.
Comment on
- 
  
  Mutant superoxide dismutase 1-induced IL-1beta accelerates ALS pathogenesis.Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13046-50. doi: 10.1073/pnas.1002396107. Epub 2010 Jun 28. Proc Natl Acad Sci U S A. 2010. PMID: 20616033 Free PMC article.
References
- 
    - Rothstein JD. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol. 2009;65(Suppl 1):S3–S9. - PubMed
 
- 
    - Bartfai T, et al. Interleukin-1 system in CNS stress: Seizures, fever, and neurotrauma. Ann N Y Acad Sci. 2007;1113:173–177. - PubMed
 
- 
    - Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009;27:519–550. - PubMed
 
Publication types
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Medical
- Miscellaneous
 
        